lysine has been researched along with exenatide in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Al-Sabah, S; Donnelly, D | 1 |
Chae, SY; Choi, YG; Jung, SY; Lee, DS; Lee, KC; Son, S | 1 |
Benoist, C; Gaglia, J; Kohler, RH; Kulkarni, RN; Li, L; Liew, CW; Mathis, D; Reiner, T; Thurber, G; Upadhyay, R; Vinegoni, C; Weissleder, R | 1 |
Chae, SY; Kim, K; Lee, KC; Lim, SM; Na, DH; Park, EJ; Son, S | 1 |
4 other study(ies) available for lysine and exenatide
Article | Year |
---|---|
The positive charge at Lys-288 of the glucagon-like peptide-1 (GLP-1) receptor is important for binding the N-terminus of peptide agonists.
Topics: Amino Acid Sequence; Amino Acid Substitution; Binding, Competitive; Cells, Cultured; Cyclic AMP; Exenatide; Glucagon-Like Peptide-1 Receptor; Humans; Inhibitory Concentration 50; Kidney; Ligands; Lysine; Molecular Sequence Data; Peptide Fragments; Peptides; Radioligand Assay; Receptors, Glucagon; Recombinant Proteins; Sequence Homology, Amino Acid; Transfection; Venoms | 2003 |
The fatty acid conjugated exendin-4 analogs for type 2 antidiabetic therapeutics.
Topics: Animals; Antigens; Diabetes Mellitus; Diabetes Mellitus, Type 2; Exenatide; Fatty Acids; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Half-Life; Hypoglycemic Agents; Lysine; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Palmitic Acid; Peptides; Rats; Rats, Sprague-Dawley; Receptors, Glucagon; Venoms | 2010 |
Accurate measurement of pancreatic islet beta-cell mass using a second-generation fluorescent exendin-4 analog.
Topics: Amino Acid Sequence; Animals; Binding Sites; Cell Line, Tumor; Diabetes Mellitus, Type 1; Exenatide; Fluorescent Dyes; Glucagon-Like Peptide-1 Receptor; Green Fluorescent Proteins; HEK293 Cells; Humans; Insulin-Secreting Cells; Laparoscopy; Lysine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Confocal; Microscopy, Fluorescence; Molecular Sequence Data; NIH 3T3 Cells; Pancreas; Peptides; Receptors, Glucagon; Streptozocin; Venoms | 2011 |
Mono-lithocholated exendin-4-loaded glycol chitosan nanoparticles with prolonged antidiabetic effects.
Topics: Animals; Chitosan; Diabetes Mellitus, Type 2; Drug Carriers; Drug Liberation; Exenatide; Hypoglycemic Agents; Lithocholic Acid; Lysine; Mice; Nanoparticles; Particle Size; Peptides; Succinimides; Venoms | 2015 |